23.5 C
New York
Monday, June 8, 2026

Tag: investors section

Jazz Pharmaceuticals Announces U.S. FDA Approval of Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma

Modeyso is the first treatment option for this ultra-rare and aggressive brain tumor, which primarily affects children and young adults Accelerated approval based on an...

BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025

MELVILLE, N.Y., Aug. 05, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced that it will release its second quarter 2025 financial results after market close on Tuesday, August 12, 2025. Following the announcement, BioRestorative management will host a conference call to review the financial results and provide a business update.

REGAL REXNORD REPORTS STRONG SECOND QUARTER 2025 FINANCIAL RESULTS

MILWAUKEE, Aug. 5, 2025 /PRNewswire/ -- Regal Rexnord Corporation (NYSE: RRX) 2Q Highlights Diluted EPS Of $1.19; Adjusted Diluted EPS* Of $2.48, Up 8.3% Versus PYDaily...

Elme Communities Announces Second Quarter 2025 Results

BETHESDA, Md., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Elme Communities (the “Company” or “Elme”) (NYSE: ELME), a multifamily REIT, reported financial and operating results today for the quarter ended June 30, 2025:

Sealed Air Names Kristen Actis-Grande Chief Financial Officer

CHARLOTTE, N.C., Aug. 4, 2025 /PRNewswire/ -- Sealed Air Corporation (NYSE: SEE) today announced Kristen Actis-Grande will join the company as Chief Financial Officer,...

Consolidated Water Sets Second Quarter 2025 Investor Conference Call for Tuesday, August 12, 2025 at 11:00 a.m. ET

GEORGE TOWN, Cayman Islands, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading designer, builder and operator of advanced water supply and treatment plants, will hold a conference call on Tuesday, August 12, 2025 at 11:00 a.m. Eastern time to discuss its results for the second quarter ended June 30, 2025.

Nektar to Announce Financial Results for the Second Quarter on Thursday, August 7, 2025, After Close of U.S.-Based Financial Markets

SAN FRANCISCO, July 31, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the second quarter on Thursday, August 7, 2025, after the...

InterDigital Announces Financial Results for Second Quarter 2025

Samsung arbitration decision and new HP license agreement drive Q2 results, exceeding outlook
Annualized recurring revenue1, at all-time high of $553 million, up 44% YoY
Company raises full year 2025 revenue guidance by $110 million

Lightspeed Announces First Quarter 2026 Financial Results

Total revenue in the quarter of $304.9 million grew 15% year-over-year and exceeded outlook Gross margin improved to 42%, with gross profit increasing 19% year-over-year exceeding...

Agios Reports Second Quarter 2025 Financial Results and Provides Business Update

Agios Pharmaceuticals today announced financial results and updates for the second quarter ended June 30, 2025.

CPKC second quarter delivers strong growth, carries momentum into second half of 2025

CALGARY, AB, July 30, 2025 /CNW/ - Canadian Pacific Kansas City (TSX: CP) (NYSE: CP) (CPKC) today announced its second-quarter results, including revenues of $3.7...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsInvestors section